Quinolines as FGFR kinase modulators
US10039759B2 · kind B2 · utility
11Cited by
30References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 8, 2016 |
| Grant date | Aug 7, 2018 |
| Priority date | — |
| Expiry date | Jul 8, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to new quinoline derivative compounds of formula (I), to pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.